phospholipase A2 receptor (PLA2R) IgG in serum

^[1]^[2]^[3]^[4]^[5]^[6]

Indications

↑ FDA News Release. May 29, 2014 FDA allows marketing of first non-invasive test to help in identifying cause of certain kidney disease. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm399327.htm (News release archived, paste https://... into browser) https://archive-it.org/collections/7993?q=first+non-invasive+test+to+help+in+identifying+cause+of+certain+kidney+disease&show=ArchivedPages&hitsPerDupe=0&go=Search+the+Archive https://wayback.archive-it.org/7993/20161023125524/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm399327.htm
↑ Loinc
↑ ARUP Laboratories Phospholipase A2 Receptor (PLA2R) Antibody, IgG with Reflex to Titer. http://ltd.aruplab.com/Tests/Pub/2011828
↑ Mayo Medical Laboratories Test ID: PLA2R. Phospholipase A2 Receptor Antibodies, Serum http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/64327
↑ Qin W, Beck LH Jr, Zeng C et al Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011 Jun;22(6):1137-43. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21566055 Free PMC Article
↑ Ardalan MR, Nasri H. Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts. J Res Med Sci. 2013 Jun;18(6):459-61. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24250691 Free PMC Article